Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077753080> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2077753080 endingPage "694" @default.
- W2077753080 startingPage "691" @default.
- W2077753080 abstract "Among 35 patients with relapsed or refractory acute myelogenous leukemia (AML) who received salvage chemotherapy, 28 were treated with mitoxantrone (7.5 mg/m2/d intravenously [IV] over 1 hour for 5 days) and etoposide (VP-16) (2 g/m2 over 4 days either as a daily infusion or as two daily doses). Seven patients received mitoxantrone (6 mg/m2/d for 5 days) and VP-16 (1500 mg/m2 over 3 days). The median duration of the initial complete remission (CR) was 6 months and 83% of the patients had initial CR that lasted 12 months or less. Forty-six percent of the patients were undergoing a second or subsequent salvage attempt. Eight patients (23%) achieved CR; seven of these CR were obtained after one course of therapy. Twelve patients (33%) died and 15 patients (42%) had disease that was resistant to treatment. Patients undergoing a first salvage attempt had a higher incidence rate of CR than those undergoing a second or subsequent salvage attempt (37% versus 6%; P = 0.03). CR rates were also higher in patients with a favorable (translocation 8;21 or 15;17) or diploid karyotype compared with other patients (32% versus 8%; P = 0.10). The median survival time was 2 months for all patients and 8 months for patients achieving CR. Mucositis occurred in 74% of the patients and was severe in 32%. Diarrhea and rash occurred in less than 33% of the patients. Fever was noticed in all but 1 of the patients and documented infections occurred in 65% of the patients. Six patients had pancytopenia or thrombocytopenia that lasted more than 42 days from the initiation of treatment. Although mitoxantrone and high-dose VP-16 is an effective antileukemic regimen, it is associated with a high incidence of mucositis. Strategies that are used to limit mucosal damage may improve the tolerance of this combination." @default.
- W2077753080 created "2016-06-24" @default.
- W2077753080 creator A5006104041 @default.
- W2077753080 creator A5027575595 @default.
- W2077753080 creator A5028026524 @default.
- W2077753080 creator A5030171128 @default.
- W2077753080 creator A5057920623 @default.
- W2077753080 creator A5066206647 @default.
- W2077753080 creator A5090435894 @default.
- W2077753080 date "1991-08-15" @default.
- W2077753080 modified "2023-10-12" @default.
- W2077753080 title "Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia" @default.
- W2077753080 cites W110083684 @default.
- W2077753080 cites W1709114039 @default.
- W2077753080 cites W1860795225 @default.
- W2077753080 cites W2010964398 @default.
- W2077753080 cites W2033288995 @default.
- W2077753080 cites W2076426515 @default.
- W2077753080 cites W2092766083 @default.
- W2077753080 cites W2111276915 @default.
- W2077753080 cites W2115587079 @default.
- W2077753080 cites W2121031553 @default.
- W2077753080 cites W2145341422 @default.
- W2077753080 cites W2167302235 @default.
- W2077753080 cites W4293241248 @default.
- W2077753080 doi "https://doi.org/10.1002/1097-0142(19910815)68:4<691::aid-cncr2820680404>3.0.co;2-z" @default.
- W2077753080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1855168" @default.
- W2077753080 hasPublicationYear "1991" @default.
- W2077753080 type Work @default.
- W2077753080 sameAs 2077753080 @default.
- W2077753080 citedByCount "21" @default.
- W2077753080 countsByYear W20777530802014 @default.
- W2077753080 countsByYear W20777530802016 @default.
- W2077753080 crossrefType "journal-article" @default.
- W2077753080 hasAuthorship W2077753080A5006104041 @default.
- W2077753080 hasAuthorship W2077753080A5027575595 @default.
- W2077753080 hasAuthorship W2077753080A5028026524 @default.
- W2077753080 hasAuthorship W2077753080A5030171128 @default.
- W2077753080 hasAuthorship W2077753080A5057920623 @default.
- W2077753080 hasAuthorship W2077753080A5066206647 @default.
- W2077753080 hasAuthorship W2077753080A5090435894 @default.
- W2077753080 hasConcept C121332964 @default.
- W2077753080 hasConcept C126322002 @default.
- W2077753080 hasConcept C141071460 @default.
- W2077753080 hasConcept C142424586 @default.
- W2077753080 hasConcept C2776694085 @default.
- W2077753080 hasConcept C2778119113 @default.
- W2077753080 hasConcept C2778461978 @default.
- W2077753080 hasConcept C2778496288 @default.
- W2077753080 hasConcept C2778570526 @default.
- W2077753080 hasConcept C2780775027 @default.
- W2077753080 hasConcept C2780923524 @default.
- W2077753080 hasConcept C71924100 @default.
- W2077753080 hasConcept C87355193 @default.
- W2077753080 hasConcept C90924648 @default.
- W2077753080 hasConceptScore W2077753080C121332964 @default.
- W2077753080 hasConceptScore W2077753080C126322002 @default.
- W2077753080 hasConceptScore W2077753080C141071460 @default.
- W2077753080 hasConceptScore W2077753080C142424586 @default.
- W2077753080 hasConceptScore W2077753080C2776694085 @default.
- W2077753080 hasConceptScore W2077753080C2778119113 @default.
- W2077753080 hasConceptScore W2077753080C2778461978 @default.
- W2077753080 hasConceptScore W2077753080C2778496288 @default.
- W2077753080 hasConceptScore W2077753080C2778570526 @default.
- W2077753080 hasConceptScore W2077753080C2780775027 @default.
- W2077753080 hasConceptScore W2077753080C2780923524 @default.
- W2077753080 hasConceptScore W2077753080C71924100 @default.
- W2077753080 hasConceptScore W2077753080C87355193 @default.
- W2077753080 hasConceptScore W2077753080C90924648 @default.
- W2077753080 hasIssue "4" @default.
- W2077753080 hasLocation W20777530801 @default.
- W2077753080 hasLocation W20777530802 @default.
- W2077753080 hasOpenAccess W2077753080 @default.
- W2077753080 hasPrimaryLocation W20777530801 @default.
- W2077753080 hasRelatedWork W1976396371 @default.
- W2077753080 hasRelatedWork W2040492280 @default.
- W2077753080 hasRelatedWork W2062064479 @default.
- W2077753080 hasRelatedWork W2074821846 @default.
- W2077753080 hasRelatedWork W2076411732 @default.
- W2077753080 hasRelatedWork W2077753080 @default.
- W2077753080 hasRelatedWork W2092766083 @default.
- W2077753080 hasRelatedWork W3025665411 @default.
- W2077753080 hasRelatedWork W94908146 @default.
- W2077753080 hasRelatedWork W2187348248 @default.
- W2077753080 hasVolume "68" @default.
- W2077753080 isParatext "false" @default.
- W2077753080 isRetracted "false" @default.
- W2077753080 magId "2077753080" @default.
- W2077753080 workType "article" @default.